Enanta Pharmaceuticals (ENTA) Interest & Investment Income (2012 - 2026)
Enanta Pharmaceuticals' Interest & Investment Income was $1.9 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), down 16.8% from $2.29 million a year earlier and down 8.8% from the prior quarter.
Enanta Pharmaceuticals (ENTA) Interest & Investment Income (2012 - 2026) Analysis & Trends
On a trailing twelve-month basis, Enanta Pharmaceuticals' Interest & Investment Income was $8.47 million through Jun 30, 2026, down 19.7% year-over-year; for FY2025 (ended Sep 30, 2025), it was $9.44 million, down 36.1% from FY2024.
- Interest & Investment Income shows a three-year compound annual growth rate of 81.7% (FY2022 to FY2025).
- In earlier fiscal years, Interest & Investment Income was $14.77 million in FY2024 (+30.0%), $11.36 million in FY2023 (+622.2%) and $1.57 million in FY2022.
- The fiscal Q3 2026 figure marks the lowest quarterly Interest & Investment Income since fiscal Q1 2018.
- Compared with a year earlier, Interest & Investment Income has declined for seven straight quarters, with an average decline of 26.2% over the last seven quarters.
- Per Business Quant data, ENTA's Interest & Investment Income in the three fiscal quarters before Q3 2026 was $2.08 million (Q2 2026), $2.42 million (Q1 2026) and $2.07 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 186.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 67.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Enanta Pharmaceuticals | 326.73 Mn | -401.27 Mn | - | 1.90 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.90 Mn |
| Mar 31, 2026 | 2.08 Mn |
| Dec 31, 2025 | 2.42 Mn |
| Sep 30, 2025 | 2.07 Mn |
| Jun 30, 2025 | 2.29 Mn |
| Mar 31, 2025 | 2.29 Mn |
| Dec 31, 2024 | 2.80 Mn |
| Sep 30, 2024 | 3.18 Mn |
| Jun 30, 2024 | 3.49 Mn |
| Mar 31, 2024 | 3.81 Mn |
| Dec 31, 2023 | 4.30 Mn |
| Dec 31, 2017 | 928,000.00 |
| Sep 30, 2017 | 783,000.00 |
| Jun 30, 2017 | 628,000.00 |
| Mar 31, 2017 | 572,000.00 |
| Dec 31, 2016 | 549,000.00 |
| Sep 30, 2016 | 497,000.00 |
| Jun 30, 2016 | 474,000.00 |
| Mar 31, 2016 | 408,000.00 |
| Dec 31, 2015 | 356,000.00 |
Enanta Pharmaceuticals Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ENTA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "ENTA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ENTA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();